Whole slide
Read the latest publication from RareCyte. Journal of Clinical Oncology: Whole-slide biomarker quantitation in 82-patient NSCLC cohort study of acquired resistance to PD-(L)1 ICI therapy Understanding the mechanisms of acquired resistance...
From HIT Consultant regarding PathAI: What You Should Know: PathAI, a pioneer in AI-powered pathology, announced a significant expansion of its PathExplore platform, adding six new oncology indications to its arsenal. The expansion...
Digital pathology is just pathology, but does it matter anymore?
- Advocacy
- Anatomic Pathology
- Artificial Intelligence
- Clinical Laboratories
- Current Affairs
- Data Management
- Digital Pathology News
- Education
- FDA Approval
- General Healthcare News
- Health Technology Collaboration
- Laboratory Management & Operations
- Microscopy
- Molecular Pathology
- Pathology News
- Personal
- Science
- TeleHealth
- Web/Tech
- Whole slide
Since the 1990s, many innovators to Fortune 500 and Fortune 50 companies have worked to make digital pathology a reality. While not mainstream and perhaps less than 10% of US based pathology groups have any serious implementations of digital...
As I mentioned about 6 months ago, our practice has adopted the use of digital pathology. While it is "digital", it is simply, pathology. At least 80% of my caseload is now viewed on a monitor. The work is done with mouse rather than...
Lumea: Enabling pathologists to use cutting-edge diagnostic solutions for decision support in Gleason grading prostate cancer specimens. LEHI, UTAH, USA, December 7, 2023 /EINPresswire.com/ -- Lumea Inc., a leader in integrated digital...
From the Grundium blog: What do pathology professionals want to know about WSI? In the dynamic world of medical diagnostics, Whole Slide Imaging (WSI) emerges as a game-changer in pathology. Many professionals grapple with its nuances as the...